U.K. and Republic of Ireland Automated External Defibrillator (AED) Market – Industry Trends and Forecast to 2031

U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Analysis and Insights

The U.K. & Republic of Ireland Automated External Defibrillator (AED) market is experiencing robust growth, driven by the demand for automated external defibrillators has surged due to their effectiveness in administering prompt defibrillation, a key factor in increasing survival rates for SCA victims. Modern automated external defibrillator devices portability and user-friendly nature have made them accessible to a broader range of individuals, including those without extensive medical training. This has resulted in a push for broader deployment in various public spaces, workplaces, and even homes, contributing to the growth of the automated external defibrillator market.

Data Bridge Market Research analyzes that the U.K. Automated External Defibrillator (AED) market is expected to reach USD 70,443.30 thousand by 2031 from USD 30,151.03 thousand in 2023, growing with a substantial CAGR of 11.3% from 2024 to 2031 and Republic of Ireland Automated External Defibrillator (AED) market is expected to reach USD 3,593.65 thousand by 2031 from USD 2,552.55 thousand in 2023, growing with a substantial CAGR of 4.5% from 2024 to 2031.

U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Definition

The industry is focused on manufacturing, distributing, and selling devices designed to automatically diagnose and treat life-threatening cardiac arrhythmias, particularly Sudden Cardiac Arrest (SCA), in emergencies. These portable electronic devices are used by bystanders, first responders, and healthcare professionals to deliver controlled electrical shocks to the heart, restoring a normal rhythm. The market encompasses various types of AEDs, including semi-automated and fully automated models, catering to diverse settings such as public spaces, healthcare institutions, and homes.

The market refers to the collective industry involved in producing, distributing, and utilizing automated external defibrillators within the U.K. and the Republic of Ireland. This market encompasses devices designed for immediate response to sudden cardiac arrests, providing a portable and automated means of delivering electric shocks to restore normal heart rhythm. Key components of the market include manufacturing companies, distributors, healthcare institutions, emergency services, and end-users such as public spaces, businesses, and individuals.

U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:     

Driver

• Increasing Incidence of Sudden Cardiac Arrest (SCA)

The Sudden Cardiac Arrest (SCA) is a life-threatening condition that can strike without warning, leading to a rapid and unexpected loss of heart function. The risk of SCA has also increased as the prevalence of cardiovascular diseases rises and the aging population grows. This has created a pressing need for effective and rapid intervention, with automated external defibrillators crucial in providing immediate treatment.

The demand for automated external defibrillators has surged due to their effectiveness in administering prompt defibrillation, a key factor in increasing survival rates for SCA victims. Modern automated external defibrillator devices' portability and user-friendly nature have made them accessible to a broader range of individuals, including those without extensive medical training. This has resulted in a push for broader deployment in various public spaces, workplaces, and even homes, contributing to the growth of the automated external defibrillator market.

Opportunity

• Technological Advancements in Automated External Defibrillator (AED)

The integration of smart technologies and connectivity features in automated external defibrillators allows for real-time monitoring and remote diagnostics. This ensures that the devices are always ready for use and provides prompt feedback to healthcare professionals and emergency responders, enhancing overall system efficiency.

Advancements in user interface design and artificial intelligence contribute to improved usability and accessibility. Modern automated external defibrillators are designed to be user-friendly, with intuitive interfaces that guide even untrained individuals through the resuscitation process. Integration of AI algorithms can aid in quick and accurate detection of cardiac rhythms, enabling the automated external defibrillator to deliver more precise and timely shocks, ultimately increasing the chances of survival during a cardiac emergency. Moreover, downsizing and portability enhancements make automated external defibrillators more versatile and suitable for various settings, including public spaces, workplaces, and homes. This broadens the potential market and encourages wider adoption of automated external defibrillators, leading to increased accessibility and improved outcomes for sudden cardiac arrest victims.

Restraints/Challenges

• High Cost Associated with Automated External Defibrillator (AED)

The initial investment required for purchasing automated external defibrillator devices, along with the cost of maintenance, training, and regulatory compliance, can pose a financial burden for organizations and individuals. This is particularly true for smaller businesses, community centers, and schools that may have budget constraints, limiting their ability to adopt and deploy automated external defibrillators on a widespread basis. As a result, the accessibility and widespread deployment of automated external defibrillators may be hindered, impacting the overall effectiveness of public access defibrillation programs.

Moreover, the high cost of automated external defibrillators may influence individual purchasing decisions, discouraging citizens from acquiring these life-saving devices for personal or community use. Potential buyers may often prioritize other health and safety investments over automated external defibrillators due to budget limitations, despite the proven benefits of automated external defibrillators in improving survival rates during sudden cardiac arrest incidents. This economic barrier could reduce the overall coverage and availability of automated external defibrillators in key locations where rapid defibrillation is crucial for saving lives.

• Lack of Training among end users to Operate  AED

Lack of training in Automated External Defibrillator (AED) operation highlights a significant concern in effectively utilizing these life-saving devices. One key challenge revolves around the insufficient training of potential users, including bystanders, in correctly operating AEDs during emergency situations. The success of AED intervention depends on quick and accurate responses, and the lack of proper training may result in hesitation or incorrect usage.

This challenge extends to various sectors, including public places, workplaces, and communities, where AEDs are commonly deployed. Inadequate training programs contribute to decreased preparedness among potential rescuers, potentially leading to delays in initiating the defibrillation process and diminishing the device's overall effectiveness.

It is observed that even though automated external defibrillators (AEDs) were available, there were delays in using them during heart emergencies. People faced challenges such as not feeling responsible and not having enough training to use the AED quickly. This is a big concern because quick AED use is crucial for saving lives during sudden heart attacks, which is expected to challenge market growth

Recent Developments

• In November 2023, Metrax GmbH MEDICA 2023, held in Düsseldorf, remains the premier global platform for the medical industry, boasting 5,598 exhibitors and 121,369 visitors in 2019. With a focus on medical technology, health, pharmaceuticals, care, and supply, this international trade fair continues to shape the future of healthcare through innovation and collaboration
• In November 2022, Progetti srl showcases advanced defibrillators, including the Rescue Life 9 professional defibrillator and the RESCUE SAM 4.0D, at MEDICA 2022. The Rescue Life 9 offers a robust TFT LCD display, extended battery life, and versatile configurations, while the RESCUE SAM 4.0D features a rapid analysis system for efficient defibrillation. Such exhibitions help the company to cater to customers attention globally
• In February 2022, Koninklijke Philips N.V. was recognized as a Top 100 Global Innovator. Philips has won a place on this prestigious list for the last eight years. This recognition will inspire the company to grow and develop in the future
• In March 2021, Asahi Kasei Corporation’s subsidiary ZOLL Medical Corporation got a USD 10 million donation to its nonprofit foundation, facilitating significant advancements in resuscitation and acute critical care research, with USD 2.5 million already granted to 69 young investigators from 14 countries. The foundation's impactful support is nurturing a new generation of researchers, fostering scientific progress in these vital fields, and ensuring continuity through mentorship for future researchers
• In November 2020, HEARTHERO achieved the CE Mark for its groundbreaking Automated External Defibrillator (AED) named "Elliot." With a focus on affordability, portability, and user-friendliness, Elliot aims to revolutionize the cardiac industry by providing immediate, accessible, life-saving technology to combat Sudden Cardiac Death globally

U.K. and Republic of Ireland Automated External Defibrillator (AED) Market Scope

The U.K. & Republic of Ireland Automated External Defibrillator (AED) market is segmented into four notable segments based on product type, application, end-user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.

Product Type

• Pneumatic Automated External Defibrillators (AED) Devices
• Automated External Defibrillators (AED) Accessories

On the basis of product type, the market is segmented into Automated External Defibrillators (AED) Devices and Automated External Defibrillators (AED) accessories.

Application

• Ventricular Fibrillation
• Pulseless Ventricular Tachycardia
• Others

On the basis of application, the market is segmented into ventricular fibrillation, pulseless ventricular tachycardia, and others.

End-User

• Pre-Hospital Care and Emergency Medical Service (EMS) Providers
• Hospitals
• Ambulatory Surgical Centers (ASC)
• Cardiac Centers
• Public Access
• Military and Defense
• Home Care Settings
• Ambulatory Care Centers
• Specialty Clinics
• Others

On the basis of technology, the market is segmented into pre-hospital care and emergency medical service (ems) providers, hospitals, ambulatory surgical centers (asc), cardiac centers, public access, military and defense, home care settings, ambulatory care centers, specialty clinics, and others.

Distribution Channel

• Direct Tender
• Online Sales
• Retail Sales
• Others

On the basis of distribution channel, the market is segmented into direct tender, online sales, retail sales, and others.

Competitive Landscape and U.K. & Republic of Ireland Automated External Defibrillator (AED) Market Share Analysis

The U.K. & Republic of Ireland Automated External Defibrillator (AED) market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points only relate to the company’s focus on the market.

Some of the major market players operating in the U.K. & Republic of Ireland Automated External Defibrillator (AED) market are Koninklijke Philips N.V, NIHON KOHDEN CORPORATION, Stryker, Asahi Kasei Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., corpuls, CU Medical Germany GmbH, Amiitalia, Cardia International A/S, SCHILLER AG, Metrax GmbH, WEINMANN Emergency Medical Technology GmbH + Co. KG, MEDIANA Co., Ltd., Progetti srl, and HEARTHERO among others.

SKU-70423